Extended staging of oesophageal cancer using FDG-PET - A critical appraisal

European Journal of Radiology

Volumn 81, Issue 1, 2012, Pages 21-30

  Marzola, Maria Cristina ^a   De Manzoni, Giovanni ^b   Grassetto, Gaia ^a   Cordiano, Claudio ^b   Al Nahhas, Adil ^c   Alavi, Abass ^d   Rubello, Domenico ^a  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Advantages; Conventional imaging; FDG PET; Limitations; Oesophageal cancer; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84855559395     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.10.018     Document Type: Review

References (46)

1. Iyer R, DuBrow R. Imaging of esophageal cancer. Cancer Imaging 2004;4:125-32.
2. Diederich S. Staging of esophageal cancer. Cancer Imaging 2007;7:S63-6.
3. Yang GY, Wagner TD, Jobe BA, Thomas Jr CR. The role of positron emission tomography in esophgeal cancer. Gastrointest Cancer Res 2008;2:3-9.
4. Wang KK. Detection and staging of esophageal cancer. Curr Opin Gastroenterol 2004;20(4):381-5. July.
5. Chou JC, Gress FG. Esophageal cancer diagnosis. http://www.healtham/cr/ esophageal-cancer-diagnosis/.
6. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010;17:1721-4.
7. Edge SB, Byrd DR, Compton CC, Fritz AG, Green FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009, 103-15.
8. Bruzzi JF, Munden RF, Truong MT, et al. PET/CT of esophageal cancer: it's role in clinical management. Radiographics 2007;27:1635-52.
9. Chowdury FU, Bradley KM, Gleeson FV. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma. Clin Radiol 2008;63:1297-309.
10. Quint LE, Hepburn LM, Francis IR, White RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995;76:1120-5.
11. Flanagan FL, Dehdasty F, Siegel BA, et al. Staging of oesophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgnol 1977;168:417-24.
12. Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 2009;29:403-21.
13. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 2008;14(10):1479-90. (Pubitemid 351460159)
14. Saftoin A, Gheonea DI. Tridimensional (3D) endoscopic ultrasound - a pictorial review. J Gastrointestin Liver Dis 2009;18(4):501-5.
15. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000;10:471-85. (Pubitemid 30626498)
16. Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-7. (Pubitemid 27435690)
17. Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002;94:921-8. (Pubitemid 34150845)
18. vanVliet EPM, Heijenbrok-Kal MH, Hunink MGM, Kuipers EJ, Siersema PD. Staging investigations for esophageal cancer: a meta-analysis. Br J Cancer 2008;98:547-57. (Pubitemid 351214529)
19. Chin BB, Wahl RL. 18F-fluoro-2-deoxyglucose in the evaluation of gastrointestinal malignancies. Gut 2003;52(Suppl 4):23-9.
20. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual modality fluorine-18-2-fluoro-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors; comparison with CT and PET. J Clin Oncol 2004;22:4357-68. (Pubitemid 41185156)
21. Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-by-side reading of PET and CT scan in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 2004;31:1456-61. (Pubitemid 39592763)
22. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005;103:148-56. (Pubitemid 39665468)
23. Flamen P. Positron emission tomography in gastric and esophageal cancer. Curr Opin Oncol 2004;16(4):359-63. (Pubitemid 38870042)
24. Bruzzi JF, Truong MT, Marom EM, et al. Incidental findings on integrated PET/CT that do not accumulate 18F-FDG. AJR Am J Roentgenol 2006;187:1116-23. (Pubitemid 44453971)
25. Rankin SC, Taylor H, Cook GJ, Mason R. Computed tomography and positron emission tomography in the preoperative staging of esophageal carcinoma. Clin Radiol 1998;53:659-65. (Pubitemid 28431974)
26. Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000;41:808-15. (Pubitemid 30266024)
27. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71(1):290-4. (Pubitemid 32102675)
28. van Westreenen, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fuorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004;22(18), 3805.12.
29. Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 2005;7(6):422-30. (Pubitemid 44193407)
30. Heeren PA, Jager PL, Bongaerts F, van Dullemen H, Sluiter V, Plukker JT. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 2004;45(6):980-7. (Pubitemid 47611685)
31. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000;232(6):743-52.
32. Meltzer CC, Lucketich JD, Friedman D, et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000;25(11):882-7.
33. Walker AJ, Spier BJ, Perlman SB, et al. Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol 2010. April 9 [Epub ahead of print].
34. Yoon HH, Lowe VJ, Cassivi SD, Romero Y. The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastrointestinal junction. Gastroenterol Clin North Am 2009;38(1):105-20.
35. Dehdasti F, Siegel BA. Neoplasms of the esophagus and stomach. Semin Nucl Med 2004;34(3):198-208. (Pubitemid 38887175)
36. Luketich JD, Friedman DM, Weigel TL, Meehan MA, Keenan RJ, Townsend DW. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999;68(4):113-6.
37. Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastrointestinal malignancy. Br J Cancer 1988;78(4):521-7.
38. Flamen P, Lerut A, van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-10.
39. Meyers BF, Downey RJ, Decker PA, et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060. J Thorac Cardiovasc Surg 2007;133(3):738-45.
40. Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study. Int J Surg 2007;5(6):399-403. (Pubitemid 350213576)
41. Duong CP, Demitriou H, Weih L, et al. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2006;33:759-69. (Pubitemid 43979683)
42. Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/ laparoscopy. Ann Thorac Surg 2002;74(4):530-4.
43. Agress Jr H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 2004;230:417-22.
44. Ishimori T, Pavel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-7.
45. van Westreenen HL, Westerterp M, Jager PL, van Dullemen HM, Sloof GW, Comans EF. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 2005;46:752-7.
46. Bar-Shalom R, Guralnik L, Tsalic M, Leiderman M, Frenkel A, Gaitini D. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2005;32:918-24. (Pubitemid 41205662)